Income Statement argenx SE

Stocks

ARGX

NL0010832176

Biotechnology & Medical Research

Market Closed - Euronext Bruxelles Other stock markets 09:25:00 10/07/2026 pm IST			5-day change	1st Jan Change
763.80 ^EUR	-4.14%		-8.06%	+6.56%

10/07	European Equities Traded in the US as American Depositary Receipts Decline Friday	MT
07/07	RBC Capital Adjusts argenx SE ADR Price Target to $945 From $890, Maintains Outperform Rating	MT

f.wHtBiyLu8dYE0zZpXcVntvNTBtq6V_aZcpNwHNe95xY.gTAqyUiFp6dSnmwIKrYDj8I1VqjzObDWMMQ_RO7npUOwPRnSV7uyr0WgVQ

Published financial data: ARGENX SE

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	50Cr	41Cr	122.63Cr	219.02Cr	415.13Cr
Other Revenues, Total	3.1Cr	3.03Cr	4.23Cr	5.8Cr	8.52Cr
Total Revenues	53Cr	44Cr	126.86Cr	224.82Cr	423.65Cr
Cost of Goods Sold, Total	58Cr	69Cr	98Cr	121.07Cr	181.48Cr
Gross Profit	-5.23Cr	-25Cr	29Cr	103.75Cr	242.17Cr
Selling General & Admin Expenses, Total	31Cr	47Cr	71Cr	105.53Cr	136.71Cr
Other Operating Expenses, Total	31Cr	47Cr	71Cr	105.53Cr	136.71Cr
Operating Income	-36Cr	-72Cr	-42Cr	-1.78Cr	105.46Cr
Interest Expense, Total	-4L	-13.43L	-7L	-20.72L	-31.75L
Interest And Investment Income	34.89L	2.47Cr	9.3Cr	14Cr	16Cr
Net Interest Expenses	30.77L	2.34Cr	9.23Cr	14Cr	16Cr
Income (Loss) On Equity Invest.	-	-7L	-44.11L	-76.44L	-1.24Cr
Currency Exchange Gains (Loss)	-5.01Cr	-3.27Cr	1.41Cr	-4.82Cr	6.58Cr
Other Non Operating Income (Expenses)	1.05Cr	-9L	-2L	-4L	-9L
EBT, Excl. Unusual Items	-40Cr	-73Cr	-32Cr	6.26Cr	126.7Cr
Gain (Loss) On Sale Of Investments	-33.38L	54.67L	1.44Cr	2.26Cr	1.16Cr
EBT, Incl. Unusual Items	-40Cr	-73Cr	-30Cr	8.52Cr	127.86Cr
Income Tax Expense	85.22L	-1.97Cr	-94.43L	-75Cr	-1.34Cr
Earnings From Continuing Operations	-41Cr	-71Cr	-30Cr	83Cr	129.2Cr
Net Income to Company	-41Cr	-71Cr	-30Cr	83Cr	129.2Cr
Net Income - (IS)	-41Cr	-71Cr	-30Cr	83Cr	129.2Cr
Net Income to Common Incl Extra Items	-41Cr	-71Cr	-30Cr	83Cr	129.2Cr
Net Income to Common Excl. Extra Items	-41Cr	-71Cr	-30Cr	83Cr	129.2Cr
Per Share Items
Net EPS - Basic	-7.99	-13.05	-5.16	13.92	21.08
Basic EPS - Continuing Operations	-7.99	-13.05	-5.16	13.92	21.08
Basic Weighted Average Shares Outstanding	5.11Cr	5.44Cr	5.72Cr	5.99Cr	6.13Cr
Net EPS - Diluted	-7.99	-13.05	-5.16	12.78	19.57
Diluted EPS - Continuing Operations	-7.99	-13.05	-5.16	12.78	19.57
Diluted Weighted Average Shares Outstanding	5.11Cr	5.44Cr	5.72Cr	6.52Cr	6.6Cr
Normalized Basic EPS	-4.85	-8.44	-3.49	0.65	12.92
Normalized Diluted EPS	-4.85	-8.44	-3.49	0.6	11.99
American Depositary Receipts Ratio (ADR)	0.04	0.04	0.04	0.04	0.04
Supplemental Items
EBITDA	-36Cr	-62Cr	-32Cr	-1.63Cr	106.19Cr
EBITA	-36Cr	-62Cr	-32Cr	-1.78Cr	105.91Cr
EBIT	-36Cr	-72Cr	-42Cr	-1.78Cr	105.46Cr
EBITDAR	-36Cr	-62Cr	-32Cr	45.65L	107.79Cr
Total Revenues (As Reported)	54Cr	45Cr	126.86Cr	225.2Cr	424.8Cr
Effective Tax Rate - (Ratio)	-2.13	2.7	3.1	-877.98	-1.05
Total Current Taxes	1.48Cr	2.72Cr	1.17Cr	5.38Cr	34Cr
Total Deferred Taxes	-63.04L	-4.69Cr	-2.11Cr	-80Cr	-35Cr
Normalized Net Income	-25Cr	-46Cr	-20Cr	3.91Cr	79Cr
Interest on Long-Term Debt	10.96L	21.93L	9L	24.64L	40.82L
Non-Cash Pension Expense	36.82L	58.07L	88.47L	1.48Cr	2.7Cr
Supplemental Operating Expense Items
Marketing Expenses	-	-	-	31Cr	40Cr
Selling and Marketing Expenses	-	-	-	31Cr	40Cr
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	58Cr	66Cr	86Cr	98Cr	136.41Cr
Net Rental Expense, Total	2L	8L	15.57L	2.09Cr	1.6Cr
Imputed Operating Lease Interest Expense	68.35T	7L	5L	1.17Cr	94.48L
Imputed Operating Lease Depreciation	2L	75.74T	10.25L	91.62L	65.87L
Stock-Based Comp., Other (Total)	18Cr	16Cr	23Cr	24Cr	25Cr
Total Stock-Based Compensation	18Cr	16Cr	23Cr	24Cr	25Cr

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	133.47Cr	80Cr	204.88Cr	149.99Cr	349.13Cr
Short Term Investments	100.21Cr	139.18Cr	113.1Cr	187.89Cr	95Cr
Total Cash And Short Term Investments	233.67Cr	219.25Cr	317.98Cr	337.88Cr	444Cr
Accounts Receivable, Total	2.81Cr	24Cr	42Cr	82Cr	148.96Cr
Other Receivables	1.02Cr	3.6Cr	8.13Cr	9.14Cr	17Cr
Total Receivables	3.82Cr	28Cr	50Cr	91Cr	165.71Cr
Inventory	11Cr	23Cr	31Cr	41Cr	47Cr
Prepaid Expenses	5.89Cr	7.6Cr	13Cr	19Cr	33Cr
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	-	-1T	-	-	-
Total Current Assets	254.3Cr	277.42Cr	412.37Cr	488.31Cr	689.91Cr
Gross Property Plant And Equipment	2.98Cr	3.43Cr	4.54Cr	7.27Cr	8.4Cr
Accumulated Depreciation	-1.4Cr	-1.8Cr	-2.27Cr	-2.92Cr	-3.57Cr
Net Property Plant And Equipment	1.58Cr	1.62Cr	2.27Cr	4.35Cr	4.82Cr
Long-term Investments	5.32Cr	4.05Cr	4.72Cr	4.97Cr	5.05Cr
Other Intangibles, Total	17Cr	17Cr	13Cr	18Cr	27Cr
Deferred Tax Assets Long-Term	3.22Cr	7.92Cr	9.72Cr	92Cr	129.59Cr
Other Long-Term Assets, Total	3.44Cr	4.92Cr	13Cr	12Cr	12Cr
Total Assets	285.03Cr	313.43Cr	454.25Cr	620.25Cr	868.27Cr
Liabilities
Accounts Payable, Total	4.52Cr	19Cr	25Cr	34Cr	55Cr
Accrued Expenses, Total	25Cr	10Cr	15Cr	29Cr	61Cr
Current Portion of Leases	35.09L	34.17L	46.46L	65.33L	1.08Cr
Current Income Taxes Payable	43.15L	31.81L	43.34L	1.34Cr	4.22Cr
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	8L	31.43L	1.76Cr	1.65Cr	9.85Cr
Total Current Liabilities	30Cr	30Cr	42Cr	67Cr	132.02Cr
Long-Term Leases	79.56L	90.09L	1.54Cr	3.25Cr	3.63Cr
Unearned Revenue Non Current	-	-	-	-	-
Pension & Other Post Retirement Benefits	4L	9L	14.49L	18.03L	30.93L
Deferred Tax Liability Non Current	64.38L	84.06L	51.55L	-	-
Total Liabilities	32Cr	32Cr	44Cr	70Cr	135.96Cr
Common Stock, Total	62.33L	66.4L	70.58L	72.27L	73.54L
Additional Paid In Capital	346.28Cr	430.99Cr	565.15Cr	594.89Cr	618.66Cr
Retained Earnings	-140.02Cr	-210.98Cr	-240.48Cr	-157.18Cr	-28Cr
Comprehensive Income and Other	47Cr	61Cr	84Cr	111.39Cr	140.9Cr
Total Common Equity	253.42Cr	281.37Cr	409.75Cr	549.83Cr	732.31Cr
Total Equity	253.42Cr	281.37Cr	409.75Cr	549.83Cr	732.31Cr
Total Liabilities And Equity	285.03Cr	313.43Cr	454.25Cr	620.25Cr	868.27Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	5.19Cr	5.56Cr	5.93Cr	6.1Cr	6.21Cr
ECS Total Common Shares Outstanding	5.17Cr	5.54Cr	5.92Cr	6.08Cr	6.19Cr
Book Value / Share	49.05	50.79	69.22	90.49	118.34
Tangible Book Value	236.25Cr	263.88Cr	397.23Cr	531.68Cr	705.1Cr
Tangible Book Value Per Share	45.73	47.64	67.11	87.5	113.94
Total Debt	1.15Cr	1.24Cr	2Cr	3.91Cr	4.72Cr
Net Debt	-232.53Cr	-218.01Cr	-315.98Cr	-333.98Cr	-439.29Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	-	-	-
Debt Equivalent Oper. Leases	17.52L	60.24L	1.25Cr	17Cr	13Cr
Equity Method Investments, Total	-	13.23L	99.12L	92.68L	33.78L
Account Code - Inventory Valuation	5	5	3	3	3
Inventories - Raw Materials, Total	7.01Cr	13Cr	24Cr	34Cr	34Cr
Inventories - Work In Process, Total	3.77Cr	6.5Cr	4.71Cr	2.64Cr	5.55Cr
Inventories - Finished Goods, Total	12.37L	3.73Cr	2.26Cr	4.3Cr	8.25Cr
Machinery, Total	82.84L	85.06L	92.41L	1.01Cr	1.17Cr
Full Time Employees	650	843	1.15T	1.6T	1.86T

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-41Cr	-71Cr	-30Cr	83Cr	129.2Cr
Depreciation & Amortization - CF	50.91L	45.76L	56.33L	72.45L	1.32Cr
Amortization of Goodwill and Intangible Assets - (CF)	3L	9.91Cr	10Cr	-	44.5L
Depreciation & Amortization, Total	53.97L	10Cr	11Cr	72.45L	1.77Cr
Amortization of Deferred Charges, Total - (CF)	5L	7L	36.74L	1.03Cr	1.04Cr
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-1.12Cr	-42.56L	-	-38.34L	-1.16Cr
(Income) Loss On Equity Investments - (CF)	-	7L	44.11L	76.44L	1.24Cr
Stock-Based Compensation (CF)	18Cr	16Cr	23Cr	24Cr	25Cr
Other Operating Activities, Total	-3.17Cr	-3.53Cr	-17Cr	-85Cr	-46Cr
Change In Accounts Receivable	-3.16Cr	-22Cr	-19Cr	-42Cr	-80Cr
Change In Inventories	-8.39Cr	-12Cr	-8.3Cr	-9.6Cr	-9.9Cr
Change In Accounts Payable	13Cr	3L	9.56Cr	25Cr	61Cr
Change in Unearned Revenues	-32Cr	-	-	-	-
Change in Other Net Operating Assets	-4.5Cr	-3.45Cr	-14Cr	-5.24Cr	-13Cr
Cash from Operations	-61Cr	-86Cr	-42Cr	-8.27Cr	69Cr
Capital Expenditure	-36.23L	-8L	-8L	-18.01L	-61.65L
Sale (Purchase) of Intangible assets	-12Cr	-10Cr	-4.3Cr	-6.65Cr	-11Cr
Investment in Marketable and Equity Securities, Total	-23Cr	-37Cr	26Cr	-76Cr	93Cr
Other Investing Activities, Total	26.03L	1.31Cr	9.28Cr	11Cr	16Cr
Cash from Investing	-35Cr	-46Cr	31Cr	-72Cr	98Cr
Long-Term Debt Repaid, Total	-38.55L	-41.65L	-38.01L	-76.38L	-41.07L
Total Debt Repaid	-38.55L	-41.65L	-38.01L	-76.38L	-41.07L
Issuance of Common Stock	112.48Cr	85Cr	135.5Cr	31Cr	28Cr
Repurchase of Common Stock	-	-58.55L	-1.21Cr	-2.19Cr	-4.13Cr
Other Financing Activities, Total	4L	-4L	-23.28L	-	-
Cash from Financing	112.13Cr	84Cr	133.67Cr	28Cr	23Cr
Foreign Exchange Rate Adjustments	-4.96Cr	-5.37Cr	2.35Cr	-2.83Cr	8.91Cr
Net Change in Cash	12Cr	-53Cr	124.81Cr	-55Cr	199.14Cr
Supplemental Items
Cash Interest Paid	7L	9L	2L	4L	9L
Cash Income Tax Paid (Refund)	1.58Cr	2.41Cr	3.75Cr	-78.01L	25Cr
Levered Free Cash Flow	-33Cr	-67Cr	-21Cr	-14Cr	51Cr
Unlevered Free Cash Flow	-33Cr	-67Cr	-21Cr	-14Cr	51Cr
Change In Net Working Capital	17Cr	37Cr	24Cr	32Cr	31Cr
Net Debt Issued / Repaid	-38.55L	-41.65L	-38.01L	-76.38L	-41.07L

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-8.77	-15.12	-6.85	-0.21	8.86
Return on Total Capital	-10.64	-16.85	-7.57	-0.23	10.21
Return On Equity %	-19.4	-26.54	-8.54	17.36	20.15
Return on Common Equity	-19.4	-26.54	-8.54	17.36	20.15
Margin Analysis
Gross Profit Margin %	-9.89	-57.09	22.96	46.15	57.16
SG&A Margin	58.24	107.06	56.12	46.94	32.27
EBITDA Margin %	-67.74	-141.31	-24.97	-0.73	25.07
EBITA Margin %	-68.07	-141.69	-25.12	-0.79	25
EBIT Margin %	-68.13	-164.15	-33.16	-0.79	24.89
Income From Continuing Operations Margin %	-77.28	-160.9	-23.26	37.05	30.5
Net Income Margin %	-77.28	-160.9	-23.26	37.05	30.5
Net Avail. For Common Margin %	-77.28	-160.9	-23.26	37.05	30.5
Normalized Net Income Margin	-46.9	-104.13	-15.71	1.74	18.69
Levered Free Cash Flow Margin	-63.3	-151.93	-16.21	-6.38	12.11
Unlevered Free Cash Flow Margin	-63.25	-151.74	-16.17	-6.32	12.15
Asset Turnover
Asset Turnover	0.21	0.15	0.33	0.42	0.57
Fixed Assets Turnover	38.52	27.5	65.21	67.93	92.33
Receivables Turnover (Average Receivables)	35.09	3.05	3.72	3.54	3.6
Inventory Turnover (Average Inventory)	8.65	4.11	3.63	3.37	4.12
Short Term Liquidity
Current Ratio	8.44	9.18	9.75	7.29	5.23
Quick Ratio	7.88	8.17	8.7	6.4	4.62
Operating Cash Flow to Current Liabilities	-2.01	-2.85	-0.99	-0.12	0.52
Days Sales Outstanding (Average Receivables)	10.4	119.65	98.11	103.25	101.43
Days Outstanding Inventory (Average Inventory)	42.21	88.89	100.63	108.49	88.57
Average Days Payable Outstanding	51.36	89.35	74.8	82.27	86.98
Cash Conversion Cycle (Average Days)	1.25	119.19	123.93	129.47	103.03
Long Term Solvency
Total Debt/Equity	0.45	0.44	0.49	0.71	0.64
Total Debt / Total Capital	0.45	0.44	0.49	0.71	0.64
LT Debt/Equity	0.31	0.32	0.37	0.59	0.5
Long-Term Debt / Total Capital	0.31	0.32	0.37	0.59	0.49
Total Liabilities / Total Assets	11.09	10.23	9.8	11.35	15.66
EBIT / Interest Expense	-873.54	-539.03	-606.98	-8.61	332.16
EBITDA / Interest Expense	-860.44	-461.87	-451.67	-5.12	337.74
(EBITDA - Capex) / Interest Expense	-869.23	-462.49	-452.84	-5.98	335.79
Total Debt / EBITDA	-0.03	-0.02	-0.06	-3.68	0.04
Net Debt / EBITDA	6.56	3.51	10.1	315.1	-4.1
Total Debt / (EBITDA - Capex)	-0.03	-0.02	-0.06	-3.15	0.04
Net Debt / (EBITDA - Capex)	6.49	3.51	10.07	269.34	-4.12
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	752.59	-16.52	187.66	77.22	88.44
Gross Profit, 1 Yr. Growth %	-83.09	381.85	-215.68	256.2	133.42
EBITDA, 1 Yr. Growth %	-25.38	74.14	-49.16	-94.85	-6.69T
EBITA, 1 Yr. Growth %	-25.17	73.77	-49.01	-94.4	-6.11T
EBIT, 1 Yr. Growth %	-25.11	101.15	-41.89	-95.76	-6.01T
Earnings From Cont. Operations, 1 Yr. Growth %	-32.9	73.81	-58.42	-382.34	55.1
Net Income, 1 Yr. Growth %	-32.9	73.81	-58.42	-382.34	55.1
Normalized Net Income, 1 Yr. Growth %	-33.84	80.29	-56.6	-119.62	1.46T
Diluted EPS Before Extra, 1 Yr. Growth %	-40.34	63.24	-60.45	-347.62	53.13
Accounts Receivable, 1 Yr. Growth %	9.68T	759.75	73.28	95.63	82.16
Inventory, 1 Yr. Growth %	332.93	109.35	36	31.13	16.28
Net Property, Plant and Equip., 1 Yr. Growth %	36.8	2.46	39.68	91.92	10.87
Total Assets, 1 Yr. Growth %	25.04	9.96	44.93	36.55	39.99
Tangible Book Value, 1 Yr. Growth %	56.8	11.69	50.53	33.85	32.62
Common Equity, 1 Yr. Growth %	51.38	11.03	45.63	34.19	33.19
Cash From Operations, 1 Yr. Growth %	52.29	42.19	-51.28	-80.31	-928.06
Capital Expenditures, 1 Yr. Growth %	239.23	-76.9	-2.99	121.8	242.31
Levered Free Cash Flow, 1 Yr. Growth %	341.32	100.38	-69.31	-30.26	-457.65
Unlevered Free Cash Flow, 1 Yr. Growth %	341.72	100.28	-69.34	-30.75	-462.3
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	138.58	166.79	54.97	125.78	82.74
Gross Profit, 2 Yr. CAGR %	-36.1	-9.72	136.09	102.99	188.34
EBITDA, 2 Yr. CAGR %	33.95	13.99	-5.91	-83.82	83.16
EBITA, 2 Yr. CAGR %	34.05	14.03	-5.87	-83.1	82.39
EBIT, 2 Yr. CAGR %	34.11	22.73	8.11	-84.3	58.34
Earnings From Cont. Operations, 2 Yr. CAGR %	50.1	7.99	-14.99	8.35	109.26
Net Income, 2 Yr. CAGR %	50.1	7.99	-14.99	8.35	109.26
Normalized Net Income, 2 Yr. CAGR %	47.08	10.47	-11.54	-70.82	103.99
Diluted EPS Before Extra, 2 Yr. CAGR %	30.52	-1.32	-19.65	-1.04	94.73
Accounts Receivable, 2 Yr. CAGR %	5.17	2.8T	285.97	84.11	88.78
Inventory, 2 Yr. CAGR %	-	201.06	68.73	33.54	23.48
Net Property, Plant and Equip., 2 Yr. CAGR %	31.41	18.39	19.63	63.73	45.87
Total Assets, 2 Yr. CAGR %	33.05	17.26	26.24	40.67	38.26
Tangible Book Value, 2 Yr. CAGR %	44.26	32.34	29.67	41.95	33.23
Common Equity, 2 Yr. CAGR %	46.52	29.64	27.16	39.79	33.69
Cash From Operations, 2 Yr. CAGR %	100.05	47.15	-16.77	-69.03	27.68
Capital Expenditures, 2 Yr. CAGR %	42.03	-11.47	-52.66	46.69	175.54
Levered Free Cash Flow, 2 Yr. CAGR %	259.56	197.38	-21.58	-53.74	57.93
Unlevered Free Cash Flow, 2 Yr. CAGR %	259.93	197.44	-21.63	-53.92	58.4
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	151.41	68.12	173.57	62.05	112.58
Gross Profit, 3 Yr. CAGR %	-5.46	25.31	-1.94	170.78	112.66
EBITDA, 3 Yr. CAGR %	56.96	46.19	-12.91	-64.27	19.44
EBITA, 3 Yr. CAGR %	56.91	46.16	-12.8	-63.25	19.23
EBIT, 3 Yr. CAGR %	56.95	53.51	-4.34	-63.26	13.36
Earnings From Cont. Operations, 3 Yr. CAGR %	75.3	57.62	-21.44	26.84	22.11
Net Income, 3 Yr. CAGR %	75.3	57.62	-21.44	26.84	22.11
Normalized Net Income, 3 Yr. CAGR %	72.28	58.87	-19.09	-46.45	19.92
Diluted EPS Before Extra, 3 Yr. CAGR %	52.19	40.62	-27.24	16.93	14.46
Accounts Receivable, 3 Yr. CAGR %	386.7	111.86	1.03T	207.74	83.46
Inventory, 3 Yr. CAGR %	-	-	131	55.13	27.52
Net Property, Plant and Equip., 3 Yr. CAGR %	156.66	20.95	25.1	40.04	43.77
Total Assets, 3 Yr. CAGR %	63.02	24.86	25.84	29.59	40.45
Tangible Book Value, 3 Yr. CAGR %	56.85	32.46	38.15	31.05	38.77
Common Equity, 3 Yr. CAGR %	60.56	33.58	34.77	29.46	37.55
Cash From Operations, 3 Yr. CAGR %	114.8	78.53	1.8	-48.53	-7.4
Capital Expenditures, 3 Yr. CAGR %	72.37	-22.47	-8.73	-20.78	94.57
Levered Free Cash Flow, 3 Yr. CAGR %	181.32	195.89	39.49	-24.59	-8.53
Unlevered Free Cash Flow, 3 Yr. CAGR %	181.24	196.04	39.46	-24.8	-8.37
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	93.44	58.5	108.35	89.17	132.8
Gross Profit, 5 Yr. CAGR %	26.11	86.35	37.11	51.98	50.96
EBITDA, 5 Yr. CAGR %	71.69	91.73	28.64	-39.38	17.23
EBITA, 5 Yr. CAGR %	71.33	91.12	28.63	-38.33	17.12
EBIT, 5 Yr. CAGR %	71.36	96.82	35.98	-38.33	17.02
Earnings From Cont. Operations, 5 Yr. CAGR %	75.81	88.26	31.99	35.67	16.25
Net Income, 5 Yr. CAGR %	75.81	88.26	31.99	35.67	16.25
Normalized Net Income, 5 Yr. CAGR %	74.75	88.93	33.45	-19.34	16.04
Diluted EPS Before Extra, 5 Yr. CAGR %	43.99	60.65	18.55	22.19	7.87
Accounts Receivable, 5 Yr. CAGR %	85.67	205.73	346.12	100.29	453.4
Inventory, 5 Yr. CAGR %	-	-	-	-	79.81
Net Property, Plant and Equip., 5 Yr. CAGR %	78.63	86.35	90.21	36.52	33.03
Total Assets, 5 Yr. CAGR %	88.33	51.22	48.01	30.96	30.67
Tangible Book Value, 5 Yr. CAGR %	100.98	48.24	46.18	36.18	36.16
Common Equity, 5 Yr. CAGR %	103.8	50.15	47.09	36.03	34.33
Cash From Operations, 5 Yr. CAGR %	118.97	85.71	47.84	-11.41	11.45
Capital Expenditures, 5 Yr. CAGR %	30.55	17.82	3.38	0.06	41.99
Levered Free Cash Flow, 5 Yr. CAGR %	97.59	147.86	69.73	40.85	46.59
Unlevered Free Cash Flow, 5 Yr. CAGR %	97.56	147.8	69.66	40.68	46.75